- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Aspirin With Chemotherapy Could Improve Survival in a Cohort of Stage III Colon Cancer Patients
Recent research has raised the possibility that low-dose aspirin could add extra years to the lives of colon cancer patients. Now, a new study suggests that only certain patients may gain a survival benefit by taking aspirin after diagnosis.
Recent research has raised the possibility that low-dose aspirin could add extra years to the lives of colon cancer patients. Now, a new study suggests that only certain patients may gain a survival benefit by taking aspirin after diagnosis.
JAMA Internal Medicine
The study of about 1,000 patients found that people whose tumor cells give off a specific antigen, or defense mechanism, gained most from adding aspirin to their regular treatment.The findings, published online March 31 in , aren't conclusive, and patients who develop colon cancer while already taking aspirin may not get any benefit. Also, aspirin, while inexpensive, comes with its own risks.
Experts asked if colon cancer patients should begin taking aspirin as a result of these findings were divided.
"Absolutely not," said study lead author Dr. Marlies Reimers, a doctoral student at Leiden University Medical Center in the Netherlands. She believes more research is necessary. But the author of a commentary accompanying the study, Dr. Alfred Neugut, said he now plans to recommend aspirin therapy for specific patients.
Read the complete report here: http://1.usa.gov/1pLfFz6
Source: Medline Plus
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
